Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor α and Cyclin D1

Joan S. Lewis-Wambi, Helen Kim, Ramona Curpan, Ronald Grigg, Mohammed A. Sarker and V. Craig Jordan
Molecular Pharmacology October 2011, 80 (4) 610-620; DOI: https://doi.org/10.1124/mol.111.072249
Joan S. Lewis-Wambi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramona Curpan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Grigg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed A. Sarker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Craig Jordan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 80 no. 4 610-620
DOI 
https://doi.org/10.1124/mol.111.072249
PubMed 
21737572

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received March 14, 2011
  • Accepted July 7, 2011
  • Published online September 21, 2011.

Article Versions

  • Earlier version (July 7, 2011 - 10:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Joan S. Lewis-Wambi,
  2. Helen Kim,
  3. Ramona Curpan,
  4. Ronald Grigg,
  5. Mohammed A. Sarker and
  6. V. Craig Jordan
  1. Women's Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania (J.S.L.W.); Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (V.C.J., H.K.); Institute of Chemistry, Romanian Academy, Timisoara, Romania (R.C.); and School of Chemistry, University of Leeds, Leeds, United Kingdom (R.G., M.A.S.)
  1. Address correspondence to:
    Dr. Joan Lewis-Wambi, Women's Cancer Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. E-mail: joan.lewis{at}fccc.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2011 to March 2021

AbstractFullPdf
Jul 20111800169
Aug 201173098
Sep 20112561099
Oct 20113433676
Nov 2011991447
Dec 20111041239
Jan 2012852649
Feb 2012482237
Mar 2012621828
Apr 2012461318
May 2012571224
Jun 2012361725
Jul 201238920
Aug 201237622
Sep 2012481725
Oct 2012461929
Nov 2012352837
Dec 2012461531
Jan 2013774732
Feb 2013302037
Mar 201328726
Apr 2013451620
May 201329919
Jun 2013312528
Jul 2013391822
Aug 2013161812
Sep 2013251215
Oct 2013292719
Nov 2013251015
Dec 2013241917
Jan 2014211624
Feb 2014171212
Mar 2014112328
Apr 2014301623
May 2014311520
Jun 2014202625
Jul 2014252311
Aug 2014221620
Sep 2014171618
Oct 2014271412
Nov 2014232011
Dec 2014121812
Jan 2015262216
Feb 2015292129
Mar 20153146348
Apr 20157822739
May 20155824679
Jun 20155127550
Jul 20158823584
Aug 20153523614
Sep 2015582439
Oct 2015201712
Nov 2015241511
Dec 201511611
Jan 2016301216
Feb 2016351122
Mar 2016141315
Apr 2016382626
May 2016191315
Jun 2016181011
Jul 2016261015
Aug 201631919
Sep 2016241317
Oct 2016112219
Nov 201612119
Dec 201662116
Jan 201721816
Feb 201712613
Mar 2017133837
Apr 201732931
May 201791912
Jun 20176278
Jul 201711107
Aug 20177126
Sep 20175117
Oct 201752111
Nov 201751610
Dec 20177203
Jan 201893317
Feb 201863125
Mar 201845134
Apr 201822616
May 20182338
Jun 20181224
Jul 20183187
Aug 20187158
Sep 201801810
Oct 201842023
Nov 201822412
Dec 201815413
Jan 20195548
Feb 20192714
Mar 201949516
Apr 20194616
May 20192706
Jun 201938314
Jul 20191312
Aug 201936310
Sep 20192338
Oct 20192847
Nov 20194657
Dec 20192336
Jan 20201726
Feb 20202300
Mar 20202442
Apr 20201400
May 20201200
Jun 20204052
Jul 20202510
Aug 2020929
Sep 20201432
Oct 20203601
Nov 20202944
Dec 20202737
Jan 20213185
Feb 202149218
Mar 2021710

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 80 (4)
Molecular Pharmacology
Vol. 80, Issue 4
1 Oct 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor α and Cyclin D1
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Bazedoxifene Inhibits Endocrine-Resistant Breast Cancer

Joan S. Lewis-Wambi, Helen Kim, Ramona Curpan, Ronald Grigg, Mohammed A. Sarker and V. Craig Jordan
Molecular Pharmacology October 1, 2011, 80 (4) 610-620; DOI: https://doi.org/10.1124/mol.111.072249

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Bazedoxifene Inhibits Endocrine-Resistant Breast Cancer

Joan S. Lewis-Wambi, Helen Kim, Ramona Curpan, Ronald Grigg, Mohammed A. Sarker and V. Craig Jordan
Molecular Pharmacology October 1, 2011, 80 (4) 610-620; DOI: https://doi.org/10.1124/mol.111.072249
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of Celecoxib targets by label-free TPP
  • Editing TOP2α Intron 19 5′ SS Circumvents Drug Resistance
  • CTS Bias
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics